ELOVL6 and metabolic dysfunction-associated steatohepatitis: In fact, the activities of fatty acid desaturase 1 (FADS1) and elongase 6 (ELOVL6) were decreased in MASH patients, and their role in the progression of simple steatosis to MASH is a subject currently under intense investigation [36].